Admission Date:  [**2185-10-7**]              Discharge Date:   [**2185-10-11**]   Service: NEUROLOGY  Allergies: Erythromycin Base / Penicillins / Tetracyclines / Iodine Containing Agents Classifier  Attending:[**First Name3 (LF) 618**] Chief Complaint: RIGHT face weakness and inability to speak  Major Surgical or Invasive Procedure: 0.9mg/kg IV t-PA  History of Present Illness: 84 yo RHM with multiple vascular risk factors including coumadin-na ve atrial fibrillation presents with rapid-onset of RIGHT facial weakness and mutism between 10:30-12PM today.
The patient was transferred to the ICU for close post-procedure monitoring.
In [**2178**], the patient underwent a procedure to examine the pleural fluid as well as a lung biopsy, both of which did not reveal a clear etiology to the source of the patient's effusion.
The patient at that time also had a pericardial window procedure performed for a pericardial effusion.
CN: I--not tested; II,III-PERRLA [**1-25**] b/l, VFF by confrontation; III,IV,VI-EOMI w/o nystagmus, no ptosis; V--sensation intact to LT/PP, masseters strong symmetrically; VII-there is dense RIGHT facial weakness sparing the forehead; IX,X--voice nasal, palate elevates symmetrically, uvula midline, gag weakly intact; [**Doctor First Name 81**]-- SCM/trapezii [**3-31**]; XII--tongue protrudes midline, no atrophy or fasciculation.
Strength:   Tri  [**Hospital1 **] FE  WE  IP R  4+  5  5   5   5 L  5   5  5   5   5  Refl: |[**Hospital1 **] |tri |bra |pat |[**Doctor First Name **] |toe | L | 2 | 2 | 2 | 2 | 1 | mute | R | 2 | 2 | 2 | 2 | 1 | up |  [**Last Name (un) **]: LT intact without extinction Gait: pt has repeatedly deferred gait testing   Pertinent Results: The patient was admitted to the Neuro ICU [**2185-10-10**] 07:30AM BLOOD WBC-10.5 RBC-4.40* Hgb-14.2 Hct-41.0 MCV-93 MCH-32.4* MCHC-34.8 RDW-14.5 Plt Ct-119*# [**2185-10-10**] 07:30AM BLOOD WBC-10.5 RBC-4.40* Hgb-14.2 Hct-41.0 MCV-93 MCH-32.4* MCHC-34.8 RDW-14.5 Plt Ct-119*# [**2185-10-10**] 07:30AM BLOOD Plt Ct-119*# [**2185-10-10**] 07:30AM BLOOD Glucose-88 UreaN-21* Creat-1.2 Na-140 K-4.9 Cl-103 HCO3-27 Calcium-8.4 Phos-3.5 Mg-1.9 [**2185-10-8**] 02:52AM BLOOD CK(CPK)-27* [**2185-10-7**] 08:47PM BLOOD CK(CPK)-24* [**2185-10-7**] 05:14PM BLOOD CK(CPK)-24* [**2185-10-8**] 02:52AM BLOOD CK-MB-NotDone cTropnT-0.03* [**2185-10-7**] 08:47PM BLOOD CK-MB-NotDone cTropnT-0.03* [**2185-10-7**] 05:14PM BLOOD CK-MB-NotDone cTropnT-<0.01  [**2185-10-8**] 02:52AM BLOOD %HbA1c-6.2* [Hgb]-DONE [A1c]-DONE [**2185-10-8**] 02:52AM BLOOD Triglyc-171* HDL-39 CHOL/HD-5.5 LDLcalc-140*  Brief Hospital Course: Dr. [**Known lastname 101490**] was diagnosed with an embolic stroke of the MCA territory, his NIH stroke scale was calculated at 12 - he had a dense RIGHT facial weakness in an UMN distribution and he was essentially mute; he had little observed focal weakness of his extremities at this time.
He receieved IV t-PA at 0.9mg/kg and was transferred to the Neuro-ICU for close monitoring.
An NGT was placed for nutritional purposes.
Because  of his atrial fibrillation, he has reluctantly agreed to begin warfarin which was started [**2185-10-10**] PM at 5mg QHS.
He has required several boluses of IV furosemide to improve his urine output.
His oxygen requirement has been 2L NC to mainatin Pox>95%.
CXRs have revealed a stable chronic RIGHT pleural effusion, cardiomegaly, and some discoid atelectasis.
Ciprofloxacin was started.
With regard to nutrition, Dr. [**Known lastname 101490**] failed a speech and swallow evaluation with solids and liquids.
He was started on tube feeding [**2185-10-10**] with Promote w/fiber.
Medications on Admission: Glipizide 2.5 mg daily Metoprolol 100mg daily Spironolactone 25 mg daily Zoloft 25 mg daily  Discharge Medications: 1.
Bisacodyl 5 mg Tablet, Delayed Release (E.C.)
Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 3 days.
Famotidine 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed.
Zoloft 20 mg/mL Concentrate Sig: Twenty Five (25) mg PO once a day: per NGT.
Warfarin 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime): Please adjust dose to INR 2.0-2.5.
Disp:*10 Tablet(s)* Refills:*0*   Discharge Disposition: Extended Care  Facility: [**Hospital6 459**] for the Aged - Acute Rehab  Discharge Diagnosis: LEFT MCA stroke RIGHT facial paresis Dysarthria and tongue apraxia Urinary Retention UTI Borderline dementia   Discharge Condition: Hemodynamically stable.
An NGT was placed for oral nutrition.
He is being treateed for a UTI with ciprofloxacin 400 q12h Warfarin was started [**2185-10-10**], INR needs to be monitored with goal of 2.0-2.5, please adjust warfarin dose accordingly   Discharge Instructions: Discharge to [**Hospital1 100**] Home for rehabilitation  Followup Instructions: Follow-up visit in [**12-30**] months with Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **]/Dr.
